Poltreg S.A. (PTG.WA)

51.60 +1.60 (+3.20%) At close: 05:00PM CEST

Poltreg S.A.

Waly Piastowskie 1 lok. 1508
Gdansk 80-855
Poland
48 512 53 24 01
https://poltreg.tech

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 25

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Piotr Trzonkowsk	President of the Management Board	1.24M	N/A	N/A
Ms. Kamilla Agnieszka Bok	Member of the Management Board & Director of Operations	330k	N/A	N/A
Mr. Mariusz Jablonski	Member of the Management Board	357k	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in PLN.

Description

Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases. It engages in the research and development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.

Corporate governance

Poltreg S.A.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.